. 2014 Oct 18;1(1):27–29. doi: 10.1016/j.jdcr.2014.10.005

Table I.

Demographic and clinical data of patients with testosterone-induced acne fulminans

Reference	Sex	No. of patients	Age	Clinical context	Therapeutic regimen	Therapy received for acne fulminans
Genetic Disorders
Hartmann and Burg, 1989¹	M	1	19	Klinefelter syndrome	Testosteron enantat 500 mg every 2 wk over 18 mo	Isotretinoin therapy over 16 weeks
Wollina et al, 2005⁴	M	1	12	Marfan syndrome	Testosterone 50 mg every 2 wk for 6 mo	Clindamycin 300 mg, prednisolone 1 mg/kg, and isotretinoin 0.5 mg/kg. Prednisolone switched for dapsone 100 mg/d (disagreement of patient's mother to continue steroid treatment)
Current case	M	2	18	Kallmann syndrome	Testosterone 250 mg once a mo over 10 mo	Systemic corticosteroid 0.5 mg/kg/d, isotretinoin 0.06 mg/kg/d
Tall Stature Treatment
Traupe et al, 1988²	M	3	13-16	Excessively tall stature	High doses of testosterone	Oral isotretinoin and topical steroid (2 cases) Systemic corticosteroid (1 case)
Weimann and Bohles, 1999³	M	1	13	Hereditary tall stature treated with high dose of testosterone	Testosterone 250 mg once a wk over 6 mo	Isotretinoin therapy (0.3 mg/kg/d), methylprednisolone and cefaclor